Addison’s Disease

REDWOOD CITY, Calif., May 18, 2026 Galvanize Therapeutics has announced that the U.S. Food and Drug Administration (FDA) granted...

OVERLAND PARK, Kan., May 19, 2026 Dechra has announced that the U.S. Food and Drug Administration (FDA) approved CosACTHen®...